A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction

A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2-hr monitoring of Neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction: 6-month outcomes

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2004.11.085 ◽

2005 ◽

Vol 24 (2) ◽

pp. S62 ◽

Cited By ~ 1

Author(s):

H. Ross ◽

M. Cantarovich ◽

J. Arizon ◽

J. Orus ◽

L. Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

A 12-MONTH, MULTICENTER, RANDOMIZED, ADAPTIVE DESIGN, OPEN-LABEL STUDY TO EVALUATE THE BENEFIT OF C2 HOUR MONITORING OF NEORAL ON SAFETY AND EFFICACY OUTCOMES IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS RECEIVING BASILIXIMAB INDUCTION

10.1097/00007890-200407271-01123 ◽

2004 ◽

Vol 78 ◽

pp. 420

Author(s):

M Cantarovich ◽

H Ross ◽

J Arizon ◽

M A. Gomez ◽

L Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2009.11.260 ◽

2010 ◽

Vol 29 (2) ◽

pp. S85-S85

Author(s):

A. Zuckermann ◽

A. Keogh ◽

M.G. Crespo-Leiro ◽

D. Mancini ◽

F. Gonzalez-Vilchez ◽

...

Keyword(s):

Renal Insufficiency ◽

Calcineurin Inhibitor ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Continued Use ◽

Moderate Renal Insufficiency

A RANDOMIZED, OPEN-LABEL STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO DIFFERENT SIROLIMUS (SRL) REGIMENS WITH TACROLIMUS (TAC) + MYCOPHENOLATE MOFETIL (MMF) IN DE NOVO RENAL ALLOGRAFT RECIPIENTS: PRELIMINARY 2-YEAR SAFETY RESULTS FROM THE ORION TRIAL

10.1097/01.tp.0000332240.81508.2b ◽

2008 ◽

Vol 86 (Supplement) ◽

pp. 156 ◽

Cited By ~ 7

Author(s):

S Flechner ◽

S Cockfield ◽

J Grinyo ◽

G Russ ◽

K M. Wissing ◽

...

Keyword(s):

Mycophenolate Mofetil ◽

Renal Allograft ◽

De Novo ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

10.1097/tp.0000000000002851 ◽

2020 ◽

Vol 104 (2) ◽

pp. 374-386 ◽

Cited By ~ 1

Author(s):

Tommaso Maria Manzia ◽

Mario Carmellini ◽

Paola Todeschini ◽

Antonio Secchi ◽

Silvio Sandrini ◽

...

Keyword(s):

Wound Healing ◽

Kidney Transplant ◽

De Novo ◽

Transplant Recipients ◽

Kidney Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

The Impact

A RANDOMIZED, OPEN-LABEL STUDY TO COMPARE THE SAFETY AND EFFICACY OF CYCLOSPORINE (CSA) DOSE REDUCTION WITH CSA ELIMINATION IN DE NOVO RENAL ALLOGRAFT PATIENTS RECEIVING SIROLIMUS

10.1097/01.tp.0000332260.21413.c3 ◽

2008 ◽

Vol 86 (Supplement) ◽

pp. 157

Author(s):

H Tedesco-Silva ◽

J M. Pestana ◽

F Alfieri ◽

S See-Tai

Keyword(s):

Dose Reduction ◽

Renal Allograft ◽

De Novo ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Everolimus and Reduced-Exposure Cyclosporine in de novo Renal-Transplant Recipients: A Three-Year Phase II, Randomized, Multicenter, Open-Label Study

10.1097/01.tp.0000140486.97461.49 ◽

2004 ◽

Vol 78 (9) ◽

pp. 1332-1340 ◽

Cited By ~ 147

Author(s):

Bj??rn Nashan ◽

John Curtis ◽

Claudio Ponticelli ◽

Georges Mourad ◽

Jonathan Jaffe ◽

...

Keyword(s):

Renal Transplant ◽

Phase Ii ◽

De Novo ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study

INTENSIFIED DOSE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) FOR 6 WEEKS, IN COMBINATION WITH ANTI-IL2R INDUCTION, CYCLOSPORINE MICRO-EMULSION (CSA-ME) WITH OR WITHOUT STEROIDS, IN ADULT DE NOVO LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANT RECIPIENTS: FINAL EFFICACY AND SAFETY RESULTS OF A PROSPECTIVE MULTICENTER RANDOMIZED OPEN-LABEL STUDY: DOMINOS STUDY.

10.1097/00007890-201007272-00215 ◽

2010 ◽

Vol 90 ◽

pp. 111

Author(s):

G. Touchard ◽

Y. Lebranchu ◽

G. Mourad ◽

L. Rostaing ◽

S. Quere ◽

...

Keyword(s):

Kidney Transplant ◽

De Novo ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Kidney Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Micro Emulsion ◽

Enteric Coated

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Case Medical Research ◽

10.31525/ct1-nct03977792 ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Labialis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Recurrent Herpes ◽

Cold Sores

An Open-label Study of the Safety and Efficacy of Tag-7 Gene-modified Tumor Cell-based Vaccine in Patients With Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer

Case Medical Research ◽

10.31525/ct1-nct04180774 ◽

2019 ◽

Author(s):

Keyword(s):

Malignant Melanoma ◽

Tumor Cell ◽

Renal Cell ◽

Cell Cancer ◽

Locally Advanced ◽

Metastatic Malignant Melanoma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽